Polymeropoulos Mihael Hristos — SEC Form 4 filings
SEC reporting owner CIK 1355537. 15 Form 4 filings on record with FilingPulse; latest filed 2026-03-04.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-02-21 to 2026-03-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 14 legs across 10 filings — 110,000 shares, $504,857 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 211,407 shares, $1,508,310 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 156,235 shares @ $8.17 ($1,276,971) in Vanda Pharmaceuticals Inc., filed 2026-03-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. (VNDA) | President and CEO, Director | 15 | 14 legs · 110,000 sh · $504,857 | 3 legs · 211,407 sh · $1,508,310 | 4 |
Form 4 filings — Polymeropoulos Mihael Hristos
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-04 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Sale (S): 156,235 @ $8.17 | EDGAR |
| 2026-02-19 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/award (A): 525,000 @ $0 | EDGAR |
| 2025-08-08 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Purchase (P): 10,000 @ $4.15 | EDGAR |
| 2025-05-21 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Purchase (P): 9,519 @ $4.40 · Purchase (P): 481 @ $4.39 | EDGAR |
| 2025-05-19 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Purchase (P): 20,000 @ $4.22 | EDGAR |
| 2025-03-06 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Purchase (P): 5,000 @ $5.02 · Purchase (P): 5,000 @ $5.01 | EDGAR |
| 2025-03-05 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Purchase (P): 5,000 @ $5.01 · Purchase (P): 5,000 @ $5.03 | EDGAR |
| 2025-03-04 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Tax withholding (F): 95,999 @ $4.76 · Purchase (P): 10,000 @ $4.71 | EDGAR |
| 2025-02-28 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Purchase (P): 10,000 @ $4.76 | EDGAR |
| 2025-02-27 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Purchase (P): 10,000 @ $4.76 | EDGAR |
| 2025-02-26 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Purchase (P): 5,000 @ $4.75 · Purchase (P): 5,000 @ $4.78 | EDGAR |
| 2025-02-25 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Purchase (P): 10,000 @ $4.46 | EDGAR |
| 2025-02-20 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/award (A): 450,000 @ $0 | EDGAR |
| 2024-03-06 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Sale (S): 30,884 @ $4.24 · Sale (S): 24,288 @ $4.13 | EDGAR |
| 2024-02-21 | 4 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/award (A): 450,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1355537 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →